Comparison of INIT and Dry Needling on Trigger Points in Knee OA

Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 30, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different treatments, the Integrated Neuromuscular Inhibition Technique (INIT) and Dry Needling, to see how they affect people with knee osteoarthritis (OA). The goal is to find out which treatment helps reduce pain, improve movement, and lower the difficulty of daily activities as experienced by patients. The trial is taking place at Wah General Hospital in Taxila and will involve 50 participants, divided into two groups of 18. Participants will be assessed using various tools to measure their pain and movement before and right after they receive the treatments.

To be eligible for this study, participants should have knee osteoarthritis classified as Grade 1 or 2 and show specific signs in their leg muscles. However, those with a history of rheumatoid arthritis, autoimmune disorders, or certain other medical conditions will not be included. If you join the study, you can expect to receive one of the two treatments and will be monitored closely to see how you respond to the therapy. Your participation would contribute valuable information to help improve treatment options for knee osteoarthritis in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Osteoarthritis Grade-1 to 2 Positive jump sign Vastus medialis(75.43%), Vastus laterals(65.78%), Gastrocnemius
• Exclusion Criteria:
• • Patient with history of RA or any autoimmune disorder Any systematic Illness Patient with Varicose vein Post traumatic, Post-Surgical and Post fractured

Trial Officials